Aspercreme Pain Relieving
- Product NDC
- 41167-0570
- 11-digit product format
- 411670570
- Labeler code
- 41167
- Product ID
- 41167-0570_d71551f4-9c5a-455b-b652-1f6e6779baba
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Trolamine Salicylate
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Chattem, Inc.
- Application
- M017
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 1998-12-01
- Substance
- TROLAMINE SALICYLATE
- Active strength
- 10 g/100g
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 41167-0570 | 41167-0570-1 | D | Discontinued by firm | 2026-11-19 | |
| excluded package | package | 41167-0570 | 41167-0570-4 | D | Discontinued by firm | 2026-11-19 | |
| excluded package | package | 41167-0570 | 41167-0570-6 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 41167-0570-1 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 41167-0570-4 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 41167-0570-6 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 41167-0570-1 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 41167-0570-4 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 41167-0570-6 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 41167-0570-1 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 41167-0570-4 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 41167-0570-6 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 41167-0570-1 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 41167-0570-4 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 41167-0570-6 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 41167-0570-1 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 41167-0570-4 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 41167-0570-6 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 41167-0570-1 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 41167-0570-4 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 41167-0570-6 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 41167-0570-1 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 41167-0570-4 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 41167-0570-6 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 41167-0570-1 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 41167-0570-4 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 41167-0570-6 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 41167-0570-1 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 41167-0570-4 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 41167-0570-6 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 41167-0570-1 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 41167-0570-4 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 41167-0570-6 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 41167-0570-1 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 41167-0570-4 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 41167-0570-6 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 41167-0570-1 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 41167-0570-4 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 41167-0570-6 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Aspercreme Pain Relieving
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TROLAMINE SALICYLATE | 10 g/100g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| H8O4040BHD | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 97dd587b-ecc3-4b4b-a116-6355d3c6ea6d | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41167-0570-1 | Aspercreme Pain Relieving | 1 in 1 CARTON | CREAM | 1 | 10 | |
| 41167-0570-1 | Aspercreme Pain Relieving | 35 g in 1 TUBE | CREAM | 35 | 10 | |
| 41167-0570-3 | Aspercreme Pain Relieving | 85 g in 1 TUBE | CREAM | 85 | 10 | |
| 41167-0570-3 | Aspercreme Pain Relieving | 1 in 1 CARTON | CREAM | 1 | 10 | |
| 41167-0570-4 | Aspercreme Pain Relieving | 1 in 1 CARTON | CREAM | 1 | 10 | |
| 41167-0570-4 | Aspercreme Pain Relieving | 106 g in 1 TUBE | CREAM | 106 | 10 | |
| 41167-0570-5 | Aspercreme Pain Relieving | 142 g in 1 TUBE | CREAM | 142 | 10 | |
| 41167-0570-5 | Aspercreme Pain Relieving | 1 in 1 CARTON | CREAM | 1 | 10 | |
| 41167-0570-6 | Aspercreme Pain Relieving | 177 g in 1 BOTTLE | CREAM | 177 | 10 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 41167-0570-3 | GM - Gram | 41167-0570 | 4404b3f5-b605-4627-9a40-e0e41c44b36d | 1 | 2021-03-02 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 41167-0570 | ASPERCREME PAIN RELIEVING (TROLAMINE SALICYLATE) CREAM [CHATTEM, INC.] | 9 | Current NDC, Legacy NDC, 9 package rows | 20240217_97dd587b-ecc3-4b4b-a116-6355d3c6ea6d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SprayPain Away | CAPSAICIN | Proximity Capital Partners LLC dba Asutra | c603e999-2316-496a-e053-2995a90ab4ed | 2026-06-17 | Warnings | M017 |
| SprayPain Away Lavender | CAPSAICIN | Proximity Capital Partners LLC dba Asutra | 547e2167-ade0-ac7e-e063-6294a90a18ea | 2026-06-17 | Warnings | M017 |
| Roll Pain Away | CAPSAICIN | PROXIMITY CAPITAL PARTNERS LLC DBA ASUTRA | 547e647b-0205-221c-e063-6294a90a757c | 2026-06-17 | Warnings | M017 |
| Roll Pain Away Lemongrass | CAPSAICIN | PROXIMITY CAPITAL PARTNERS LLC DBA ASUTRA | 547ef5c0-bc31-d83e-e063-6394a90abfa6 | 2026-06-17 | Warnings | M017 |
| Roll Pain Away Lavender | CAPSAICIN | PROXIMITY CAPITAL PARTNERS LLC DBA ASUTRA | 547ef2d9-f5c7-9de1-e063-6394a90a218b | 2026-06-17 | Warnings | M017 |
| Velloryn EXTRA STRENGTH NEUROPATHY | VELLORYN EXTRA STRENGTH NEUROPATHY | GUANGZHOU YUSONG FINE CHEMICLS Co., Ltd | 547f755f-c65c-37ef-e063-6394a90aa220 | 2026-06-17 | Warnings | M017 |
| Neoteric Diabetic Skin Care 4 oz. | DIMETHICONE | RNA PHARMA LLC | 536f4e79-201b-7100-e063-6394a90a4f82 | 2026-06-16 | Warnings | M017 |
| Medi First Extra Strength Itch Relief | DIPHENHYDRAMINE, ZINC ACETATE | Unifirst First Aid Corporation | 54614e5b-8c72-d308-e063-6294a90a405d | 2026-06-16 | Warnings | M017 |
| Medi-First Hydrocortisone 1 % Anti-Itch Cream | HYDROCORTISONE | Unifirst First Aid Corporation | 49f04e5d-746d-cbe9-e063-6294a90a7e88 | 2026-06-16 | Warnings | M017 |
| Lidozall Pro | LIDOCAINE HYDROCHLORIDE | V2 Pharma LLC | ecc26ba7-4ff6-43e6-bfb9-91a9cbb509ff | 2026-06-16 | Warnings | M017 |
| Tiger Balm Pain Relieving Cool | CAMPHOR (SYNTHETIC) AND MENTHOL, UNSPECIFIED FORM | Haw Par Healthcare Ltd. | 41590ba1-32bb-4352-97ba-d6a3cc9d0546 | 2026-06-15 | Warnings | M017 |
| HIGH POTENCY PAIN RELIEF | CAPSAICIN | Xiamen Weisiqi Technology Co., Ltd. | 543949a4-86ed-3734-e063-6394a90a24f2 | 2026-06-14 | Warnings | M017 |
| Natucure HEMORRHOID | LIDOCAINE 4% PHENYLEPHRINE HCL 0.25% HEMORRHOID | Jiangxi Yudexi Pharmaceutical Co., LTD | 49e402ed-d314-e896-e063-6294a90a826b | 2026-06-14 | Warnings | M017 |
| Nieapf NUMBING | LIDOCAINE 4% NUMBING | Jiangxi Yudexi Pharmaceutical Co., LTD | 49e7534f-bccf-4ef4-e063-6294a90aeb7f | 2026-06-14 | Warnings | M017 |
| HEALMUSZ NUMBING | HEALMUSZ NUMBING | Jiangxi Yudexi Pharmaceutical Co., LTD | 49976ff7-49a4-e4ed-e063-6294a90a3f78 | 2026-06-14 | Warnings | M017 |
| HEALMUSZ HEMORRHOID FISSURE | LIDOCAINE 4% PHENYLEPHRINE HCL 0.25% HEMORRHOID FISSURE | Jiangxi Yudexi Pharmaceutical Co., LTD | 4a342ac0-6a8d-3408-e063-6394a90a9a10 | 2026-06-14 | Warnings | M017 |
| BOTASUN QUIT SMOKING Nicotine | NICOTINE18% MENTHOL 0.3% QUIT SMOKING NICOTINE | Jiangxi Yudexi Pharmaceutical Co., LTD | 4fa00db9-def5-dcfa-e063-6394a90ac8c2 | 2026-06-14 | Warnings | M017 |
| HEALMUSZ NUMBING | MENTHOL 5% NUMBING | Jiangxi Yudexi Pharmaceutical Co., LTD | 4cbb7df5-5771-ce4b-e063-6294a90aab80 | 2026-06-14 | Warnings | M017 |
| HEALMUSZ ECZEMA | HYDROCORTISONE 1% ECZEMA | Jiangxi Yudexi Pharmaceutical Co., LTD | 511e54e0-2abe-fb76-e063-6294a90ada68 | 2026-06-14 | Warnings | M017 |
| Hydrocortisone 1% Anti-ItchCream | HYDROCORTISONE | Acme United Corporation | 5425fc2b-4f25-3e64-e063-6394a90aff49 | 2026-06-13 | Warnings | M017 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1101827 | Aspercreme 10 % Topical Cream | PSN | 97dd587b-ecc3-4b4b-a116-6355d3c6ea6d | 10 |
| 313518 | trolamine salicylate 10 % Topical Cream | PSN | 97dd587b-ecc3-4b4b-a116-6355d3c6ea6d | 10 |
| 1101827 | trolamine salicylate 100 MG/ML Topical Cream [Aspercreme] | SBD | 97dd587b-ecc3-4b4b-a116-6355d3c6ea6d | 10 |
| 313518 | trolamine salicylate 100 MG/ML Topical Cream | SCD | 97dd587b-ecc3-4b4b-a116-6355d3c6ea6d | 10 |
| 1101827 | Aspercreme 10 % Topical Cream | SY | 97dd587b-ecc3-4b4b-a116-6355d3c6ea6d | 10 |
| 1101827 | Aspercreme 100 MG/ML Topical Cream | SY | 97dd587b-ecc3-4b4b-a116-6355d3c6ea6d | 10 |
| 313518 | trolamine salicylate 10 % Topical Cream | SY | 97dd587b-ecc3-4b4b-a116-6355d3c6ea6d | 10 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 41167-0570-1 | 41167057001 | 1 TUBE in 1 CARTON (41167-0570-1) > 35 g in 1 TUBE | 1 tube | 1998-12-01 | 0000-00-00 | No | No | Current |
| 41167-0570-3 | 41167057003 | 1 TUBE in 1 CARTON (41167-0570-3) / 85 g in 1 TUBE | 1 tube | 1998-12-01 | 0000-00-00 | No | No | Current |
| 41167-0570-4 | 41167057004 | 1 TUBE in 1 CARTON (41167-0570-4) > 106 g in 1 TUBE | 1 tube | 1998-12-01 | 0000-00-00 | No | No | Current |
| 41167-0570-5 | 41167057005 | 1 TUBE in 1 CARTON (41167-0570-5) / 142 g in 1 TUBE | 1 tube | 1998-12-01 | 0000-00-00 | No | No | Current |
| 41167-0570-6 | 41167057006 | 177 g in 1 BOTTLE | 177 g | Historical |